Evec

Evec is a biotech company located in Sapporo, Japan, established in 2003, based on proprietary technologies of professor Kenzo Takada at the Institute for Genetic Medicine of Hokkaido University. Evec is specialized in development of a wide spectrum of human monoclonal antibodies in multiple therapeutic areas, including cancer, inflammatory diseases and infectious diseases by an Epstein-Barr Virus Transformation Method.